Leerink analyst Puneet Souda downgraded Patheon (PTHN) to Market Perform citing the pending acquisition by Thermo Fisher (TMO). The analyst does not expect antitrust concerns. He raised his price target for Patheon shares to $35 from $31.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here